| Ytd | -41.80% | |
| 1y | -16.07% |
| Open | 1.94 | Prev Close | 1.88 | Low | 1.84 | High | 1.94 | Mkt Cap | 4.59M |
| Vol | 3.33K | Avg Vol | 15.07K | EPS | -1.95 | P/E | -0.96 | Forward P/E | -3.25 |
| Beta | -0.50 | Short Ratio | 10.12 | Inst. Own | 12.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 2.05 | 200-d Avg | 2.76 | 1yr Est | 1.75 |
TCRT News
ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, includin
FORT LAUDERDALE, Fla., May 18, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) to
Seasoned Biopharmaceutical Attorney with Deep IP, Clinical-Stage, and Nasdaq Public Company Experien
Alaunos Therapeutics Inc. (NASDAQ: TCRT) shares are down on Monday after the company announced precl
Alaunos' ALN1003 shows dose dependent weight loss, better body composition, reduced liver weight, an
Alaunos Therapeutics, Inc. (NASDAQ: TCRT - Get Free Report) saw a significant decline in short inter
Alaunos Therapeutics, Inc. (NASDAQ: TCRT - Get Free Report) was up 3.1% during mid-day trading on We
HOUSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) (the “Company”)
NEWPORT BEACH, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital”), a wholly
NEWPORT BEACH, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital,” “we,” “our
Alaunos Therapeutics (NASDAQ: TCRT ) stock is up on Monday despite a lack of news from the clinical-
Alaunos Therapeutics (NASDAQ: TCRT ) stock is heading higher on Tuesday following the release of the
HOUSTON, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (
Due to a lack of funding needs, Alaunos (TCRT) decides to end its only clinical study. The company w
HOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (
HOUSTON, May 03, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (N
HOUSTON, March 29, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”)
HOUSTON, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (
Here is how Alaunos (TCRT) and Autolus Therapeutics PLC Sponsored ADR (AUTL) have performed compared
Innovation is expected to continue driving growth in the Medical-Drugs industry in 2023. DYN, SLN, T
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Sc
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on
During Thursday, 849 stocks hit new 52-week lows.
Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market ses
On Monday, 466 companies hit new 52-week lows.
During Friday's morning session, 234 stocks hit new 52-week lows.
Gainers